Cellectar Biosciences Inc. (Nasdaq: CLRB)

Breaking

Novartis Secures Prostate Cancer Treatment With Endocyte (ECYT) Deal, $24 Per Share, Stock Was $1.21 Last August (1 of 5)

Newtek Business Services (NEWT) is Latest Company to be Added to the Main Event, Mutton Shall be Served (2 of 5)

Beats by Dre To Officially Sponsor Chris Lahiji and LD Micro, Chris Becomes First Man in Financial Services to Be Endorsed, AAPL Up Huge on Announcement (3 of 5)

Uber and Lyft Blamed for San Francisco's Congested Streets, The Sky is Blue, Earth is Round, Golden State Will Win the Championship this Year (4 of 5)

These People Have No Friends (5 of 5)

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of October 20, 2018 • 5:01 PM ET

Date/Time	Source	News Release

Additional News

As of October 20, 2018 • 5:01 PM ET

Date/Time	Source	News Release

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.

Cellectar Biosciences Inc. (Nasdaq: CLRB) Overview

Loading

Loading

Loading

Company News

Additional News